A series of novel metronidazole derivatives were designed via introduction of pharmacologically active 1,3,4-thiadiazole and Schiff base fragments into the 5-nitroimidazole skeleton of metronidazole at the 2-position without modifying the nitro group. The designed compounds were synthesized as per literature method with little modification and were isolated in moderate to good yield (68–92%) in the analytically pure form without resorting to chromatographic purification. The antibacterial activity of the newly synthesized compounds was assessed against three gram-positive bacterial strains (S. aureus, B. cereus, and S. epidermidis) and three gram-negative strains (E. coli, S. typhi, and K. pneumoniae) by standard disc diffusion method. The synthesized compounds were also tested for anthelmintic activity at a concentration of 2 mg/mL against two worm species, Pheretima posthuma and Perionyx excavatus. Three of the twelve new derivatives showed comparable antibacterial activity to that of standard but none of them exhibited anthelmintic potential.